Eosinophilic airway inflammation induced by repeated exposure to cigarette smoke

Acute exposure to cigarette smoke causes airway hyperresponsiveness (AHR) in guinea-pigs, which resolves within a few hours. Repeated exposure may have a different effect on the airways. To address this question, guinea-pigs were repeatedly exposed to cigarette smoke (six cigarettes for 1 h x day(-1)) for 14 consecutive days. Airway responsiveness to inhaled histamine and differential cell counts in bronchoalveolar lavage fluid (BALF) were evaluated 1 day after the last exposure. Significant neutrophilia in BALF was observed after 3 days of smoke exposure. Significant eosinophilia in BALF and AHR were observed after 14 days of smoke exposure, but not after 3 or 7 days of smoke exposure. These changes persisted until 3 days after the last exposure and resolved 7 days afterwards. Histologically, the recruited eosinophils were observed predominantly in the airways, but not in the alveoli. Treatment with E-6123, a specific platelet-activating factor receptor antagonist (1 mg x kg(-1) x day(-1) p.o. during smoke exposure) significantly inhibited the eosinophil influx and AHR. Repeated exposure to cigarette smoke may induce prolonged airway inflammation and airway hyperresponsiveness in guinea-pigs. Platelet-activating factor or platelet-activating factor-like lipids may play a key role in airway hyperresponsiveness, presumably by the induction of eosinophilic airway inflammation.

This article has been cited by other articles:

				V. Reichert, X. Xue, D. Bartscherer, D. Jacobsen, C. Fardellone, P. Folan, N. Kohn, A. Talwar, and C. N. Metz A Pilot Study To Examine the Effects of Smoking Cessation on Serum Markers of Inflammation in Women at Risk for Cardiovascular Disease Chest, July 1, 2009; 136(1): 212 - 219. [Abstract] [Full Text] [PDF]

				S. Kubo, M. Kobayashi, Y. Masunaga, H. Ishii, Y. Hirano, K. Takahashi, and Y. Shimizu Cytokine and chemokine expression in cigarette smoke-induced lung injury in guinea pigs Eur. Respir. J., December 1, 2005; 26(6): 993 - 1001. [Abstract] [Full Text] [PDF]

				I Vachier, A M Vignola, G Chiappara, A Bruno, H Meziane, P Godard, J Bousquet, and P Chanez Inflammatory features of nasal mucosa in smokers with and without COPD Thorax, April 1, 2004; 59(4): 303 - 307. [Abstract] [Full Text] [PDF]

				G T Verhoeven, J P J J Hegmans, P G H Mulder, J M Bogaard, H C Hoogsteden, and J-B Prins Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness Thorax, August 1, 2002; 57(8): 694 - 700. [Abstract] [Full Text] [PDF]

				M. Miravitlles Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Eur. Respir. J., July 1, 2002; 20(36_suppl): 9S - 19s. [Abstract] [Full Text] [PDF]

				J. L. Wright and A. Churg A Model of Tobacco Smoke-Induced Airflow Obstruction in the Guinea Pig* Chest, May 1, 2002; 121 (2009): 188S - 191S. [Abstract] [Full Text] [PDF]

				G. W. Chalmers, K. J. MacLeod, L. Thomson, S. A. Little, C. McSharry, and N. C. Thomson Smoking and Airway Inflammation in Patients With Mild Asthma Chest, December 1, 2001; 120(6): 1917 - 1922. [Abstract] [Full Text] [PDF]

				S. FUKUYAMA, H. INOUE, H. AIZAWA, M. OIKE, M. KITAURA, O. YOSHIE, and N. HARA Effect of Eotaxin and Platelet-activating Factor on Airway Inflammation and Hyperresponsiveness in Guinea Pigs in Vivo Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1844 - 1849. [Abstract] [Full Text]

				C. Iribarren, D. R. Jacobs Jr., S. Sidney, M. D. Gross, and M. D. Eisner Cigarette Smoking, Alcohol Consumption, and Risk of ARDS* : A 15-Year Cohort Study in a Managed Care Setting Chest, January 1, 2000; 117(1): 163 - 168. [Abstract] [Full Text] [PDF]

				S. HART;, M. CONFALONIERI, A. SPANEVELLO;, K. W TSANG;, M. CONFALONIERI, A. SPANEVELLO;, C E BRIGHTLING, I D PAVORD;, M. CONFALONIERI, and A. SPANEVELLO Inhaled corticosteroids in COPD Thorax, February 1, 1999; 54(2): 186 - 186. [Full Text]